Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00002383
What this trial is testing

A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 80
Early research (Phase 1)Study completedNCT00002218
What this trial is testing

A Phase I Maximum Tolerated Dose Study of CI-1012 in Late-Stage HIV+ Patients

Who this might be right for
HIV Infections
Parke-Davis 40
Not applicableStudy completedNCT00002168
What this trial is testing

A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Testing effectiveness (Phase 2)Study completedNCT00016718
What this trial is testing

Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 43
Not applicableStudy completedNCT00000896
What this trial is testing

Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)UnknownNCT01663168
What this trial is testing

EARNEST Rifabutin Pharmacokinetics (PK) Substudy

Who this might be right for
HIVTuberculosis
Justine Boles 140
Not applicableStudy completedNCT00038259
What this trial is testing

Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 21
Testing effectiveness (Phase 2)Study completedNCT00002210
What this trial is testing

Delavirdine Mesylate in Combination With Other Anti-HIV Drugs in HIV-Infected Children and Babies

Who this might be right for
HIV Infections
Pharmacia and Upjohn 24
Testing effectiveness (Phase 2)UnknownNCT00002451
What this trial is testing

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 8
Not applicableStudy completedNCT00002216
What this trial is testing

A Comparison of Two Multi-Drug Therapies in HIV-Infected Patients Who Have Never Received Anti-HIV Treatment

Who this might be right for
HIV Infections
Glaxo Wellcome
Early research (Phase 1)Study completedNCT00004736
What this trial is testing

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 44
Not applicableStudy completedNCT00002453
What this trial is testing

A Compassionate Use Study of Tenofovir Disoproxil Fumarate as Treatment for HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 300
Testing effectiveness (Phase 2)Study completedNCT00002423
What this trial is testing

Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Who this might be right for
HIV Infections
Glaxo Wellcome 100
Early research (Phase 1)Study completedNCT00352066
What this trial is testing

Pharmacokinetics of Apricitabine and Tipranavir When Dosed Alone or Together

Who this might be right for
HIV Infection
Avexa 18
Not applicableStudy completedNCT00080522
What this trial is testing

Strategies for Delivering Anti-HIV Therapy in South Africa

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 813
Early research (Phase 1)Study completedNCT00000920
What this trial is testing

Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns

Who this might be right for
HIV InfectionsPregnancy
National Institute of Allergy and Infectious Diseases (NIAID) 24
Large-scale testing (Phase 3)UnknownNCT00006397
What this trial is testing

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Who this might be right for
HIV Infections
PPD Development, LP 200
Testing effectiveness (Phase 2)Study completedNCT00001045
What this trial is testing

Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Large-scale testing (Phase 3)Study completedNCT00262106
What this trial is testing

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

Who this might be right for
HIV InfectionsGonorrheaChlamydial Infections+1 more
Endo USA Inc., a Keenova Therapeutics Company 9,404
Large-scale testing (Phase 3)Study completedNCT00075907
What this trial is testing

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 240
Next Page